In the OPM2 cell line, 94.2% of target cells were lysed, and there was a 1.3-fold increase in lysis of MM cells with Bi-CAR-T cells compared to CD24-CAR-T cells. The gene discussed is CD24; the disease is Miyoshi myopathy.